subject: CHEBI:52717

subject_name: Bortezomib

object_name: small intestine cancer


subject: CHEBI:52717

object_name: small intestine carcinoma

tested_intervention: yes


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: Refractory acute myeloid leukemia

tested_intervention: unsure


subject: CHEBI:44423

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C2746922

subject_name: Ablavar

object_name: nephrogenic systemic fibrosis


subject: MESH:D022341

subject_name: Yellow Fever Vaccine

object_name: systemic sclerosis


subject: MESH:D022341

object_name: mixed connective tissue disease


subject: MESH:D022341

object_name: rheumatoid arthritis


subject: MESH:D022341

object_name: inclusion body myositis


subject: MESH:D022341

object_name: myositis


subject: MESH:D022341

object_name: Inflammatory myopathy


subject: MESH:D022341

object_name: granulomatosis with polyangiitis


subject: MESH:D022341

object_name: juvenile idiopathic arthritis


subject: MESH:D022341

object_name: juvenile dermatomyositis


subject: MESH:D022341

object_name: Takayasu arteritis


subject: MESH:D022341

object_name: inflammatory spondylopathy


subject: MESH:D022341

object_name: spondyloarthropathy


subject: MESH:D022341

object_name: Sicca Syndrome


subject: UMLS:C5887900

subject_name: Yellow fever virus antigen only vaccine product


subject: UMLS:C5887900


subject: UMLS:C5887900


subject: UMLS:C5887900


subject: UMLS:C5887900


subject: UMLS:C5887900


subject: UMLS:C5887900


subject: UMLS:C5887900


subject: UMLS:C5887900


subject: UMLS:C5887900


subject: UMLS:C5887900


subject: UMLS:C5887900


subject: UMLS:C5887900


subject: CHEMBL.COMPOUND:CHEMBL2108816

subject_name: YELLOW FEVER VACCINE


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: CHEMBL.COMPOUND:CHEMBL2108816


subject: UMLS:C2356374

subject_name: yellow fever virus strain 17D-204 live antigen


subject: UMLS:C2356374


subject: UMLS:C2356374


subject: UMLS:C2356374


subject: UMLS:C2356374


subject: UMLS:C2356374


subject: UMLS:C2356374


subject: UMLS:C2356374


subject: UMLS:C2356374


subject: UMLS:C2356374


subject: UMLS:C2356374


subject: UMLS:C2356374


subject: UMLS:C2356374


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: bronchiolitis


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:16760419

object_name: Plasma cell tumor, malignant


subject: PUBCHEM.COMPOUND:16760419

object_name: plasma cell neoplasm


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: UMLS:C5392300


subject: UNII:UYB6UOF69L

subject_name: Maralixibat

object_name: biliary atresia


subject: UMLS:C5447522

subject_name: Myeloid Cell Leukemia 1 Inhibitor PRT1419

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5447522

object_name: acute myeloid leukemia


subject: UMLS:C5447522


subject: UMLS:C5447522

object_name: Myelodysplasia


subject: UMLS:C5447522

object_name: non-Hodgkin lymphoma


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: overall survival


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: UMLS:C4331803

subject_name: MDM2-p53 Inhibitor APG-115

object_name: salivary gland cancer


subject: UMLS:C4331803

object_name: salivary gland carcinoma


subject: CHEBI:5538

subject_name: Granisetron hydrochloride

object_name: Nausea, CTCAE_5


subject: CHEBI:5538

object_name: Nausea


subject: CHEBI:5538

object_name: Nausea, CTCAE_3


subject: UNII:318F6L70J8

subject_name: GRANISETRON HYDROCHLORIDE


subject: UNII:318F6L70J8


subject: UNII:318F6L70J8


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Menopause present (finding)


subject: CHEBI:31527

object_name: Menopause


subject: CHEBI:8673

subject_name: Pyrimethamine

object_name: Neck Carcinoma


subject: CHEBI:8673

object_name: head and neck neoplasm


subject: CHEBI:8673

object_name: head and neck cancer


subject: CHEBI:94688

subject_name: Acipimox

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:94688

object_name: Acute heart failure


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: heavy bleeding between periods (symptom)


subject: CHEBI:41774

object_name: Menorrhagia


subject: CHEBI:41774

object_name: Menorrhagia, CTCAE


subject: UMLS:C2745498

object_name: Drug Interactions


subject: UMLS:C5555142

subject_name: TRK Inhibitor VC004

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5555142

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4298036

subject_name: CURCUMINOIDS

object_name: Frail elderly syndrome


subject: UMLS:C4086228

subject_name: Curcuminoid


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: nicotine dependence


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: maturity-onset diabetes of the young type 1


subject: GTOPDB:13790

subject_name: benmelstobart

object_name: Stomach cancer


subject: GTOPDB:13790

object_name: gastric cancer


subject: UNII:B25CF42QKP

subject_name: BENMELSTOBART


subject: UNII:B25CF42QKP


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Non-small cell lung cancer recurrent


subject: MESH:D056692

subject_name: Prebiotics

object_name: Functional constipation


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Cyanotic heart disease


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: septic shock


subject: CHEBI:95346

subject_name: Atovaquone

object_name: non-small cell lung carcinoma


subject: MESH:C000626557

subject_name: jaungo

object_name: atopic eczema


subject: CHEBI:176381

subject_name: Diosmin

object_name: Digital ulcer


subject: CHEBI:176381

object_name: systemic sclerosis


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Iliofemoral deep vein thrombosis


subject: GTOPDB:13649

subject_name: zenocutuzumab

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL4298025

subject_name: ZENOCUTUZUMAB


subject: UMLS:C4549048


subject: CHEBI:49662

subject_name: Indomethacin

object_name: systemic inflammatory response syndrome


subject: CHEBI:7747

subject_name: oleuropein

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:7747

object_name: metabolic syndrome X


subject: CHEBI:7747

object_name: type 2 diabetes mellitus


subject: CHEBI:7747

object_name: Insulin resistance


subject: CHEBI:7747

object_name: Abdominal obesity


subject: CHEBI:7747

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:7747

object_name: obesity


subject: CHEBI:7747

object_name: Obesity, CTCAE


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Fatty pancreas


subject: UNII:939U7C91AI

subject_name: Solriamfetol

object_name: binge eating


subject: UNII:69VKY8P7EA

object_name: acute myeloid leukemia by FAB classification


subject: UNII:69VKY8P7EA

object_name: acute myeloid leukemia


subject: UMLS:C2004126

subject_name: TKI 258


subject: UMLS:C2004126


subject: CHEBI:189666

object_name: Vaso-Occlusive Crisis


subject: CHEBI:189666

object_name: sickle cell disease


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Colon Neoplasm


subject: UNII:4F4X42SYQ6

object_name: gastric neoplasm


subject: UNII:4F4X42SYQ6

object_name: breast neoplasm


subject: UNII:4F4X42SYQ6

object_name: lung neoplasm


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C3885141

object_name: pulmonary tuberculosis


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Barrett's esophagus without dysplasia


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:7773

subject_name: Ondansetron

object_name: amphetamine abuse


subject: UMLS:C3491843

object_name: Tourette syndrome


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Vasoplegia


subject: UMLS:C5690288

object_name: chronic hepatitis B virus infection


subject: UMLS:C5690288

object_name: chronic hepatitis C virus infection


subject: UNII:0T0250N43U

subject_name: peginterferon lambda-1a


subject: UNII:0T0250N43U


subject: UMLS:C4043002


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Pruritus


subject: UMLS:C3658854


subject: UMLS:C1827106

subject_name: Dipeptidyl-Peptidase IV Inhibitors

object_name: Prediabetes


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: chronic kidney disease


subject: CHEBI:84094

object_name: Chronic uremia


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:85155

subject_name: Netupitant

object_name: breast carcinoma


subject: UNII:YZS3R7LP44

subject_name: Palonosetron


subject: CHEBI:8435

subject_name: Prochlorperazine


subject: CHEBI:135935

subject_name: Tapentadol

object_name: arthropathy


subject: GTOPDB:13627

subject_name: zanidatamab

object_name: Gastroesophageal junction cancer


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB


subject: UMLS:C4331966


subject: CHEBI:31858

subject_name: Mizoribine

object_name: rheumatoid arthritis


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: hair disease


subject: UMLS:C0055108


subject: PUBCHEM.COMPOUND:85052343

subject_name: Rotigaptide

object_name: heart disorder


subject: PUBCHEM.COMPOUND:85052343

object_name: aneurysm


subject: UMLS:C1311916

subject_name: rotigaptide


subject: UMLS:C1311916


subject: UMLS:C4766143

subject_name: Glucagon for Injection

object_name: Reactive hypoglycemia


subject: CHEBI:18145

subject_name: Vitamin E

object_name: Adolescent Obesity


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: poliomyelitis


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011

object_name: acute lymphoblastic leukemia


subject: UNII:I031V2H011

object_name: myeloproliferative neoplasm


subject: UNII:I031V2H011

object_name: bone marrow neoplasm


subject: UNII:I031V2H011

object_name: Hodgkin Disease


subject: UNII:I031V2H011

object_name: Adult Hodgkin Lymphoma


subject: UNII:I031V2H011

object_name: Childhood Hodgkin Lymphoma


subject: UNII:D07V79Q44T

object_name: Mesothelioma


subject: UNII:D07V79Q44T

object_name: mesothelial neoplasm


subject: UNII:D07V79Q44T

object_name: malignant mesothelioma


subject: UNII:D07V79Q44T

object_name: non-small cell lung carcinoma


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:85990


subject: CHEBI:85990


subject: UMLS:C3714217

object_name: esophageal squamous cell carcinoma


subject: UMLS:C4287707

subject_name: Cdk4/6 inhibitor shr6390


subject: UNII:ZH5SMU97AJ

object_name: History of - respiratory disease


subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE

object_name: kidney failure


subject: PUBCHEM.COMPOUND:6917964

object_name: Renal Failure, CTCAE


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma


subject: UNII:4F4X42SYQ6

object_name: nodular lymphocyte predominant Hodgkin lymphoma


subject: UNII:4F4X42SYQ6

object_name: adult nodular lymphocyte predominant Hodgkin lymphoma


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0729218

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C0729218

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C0729218

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:233158

subject_name: Soticlestat

object_name: epilepsy


subject: CHEMBL.COMPOUND:CHEMBL2108463

subject_name: GARLIC

object_name: bleeding tendency; due to coagulation defect


subject: UMLS:C0885057

subject_name: garlic preparation


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba


subject: UMLS:C3531686

subject_name: Ginkgo biloba whole extract


subject: CHEBI:189965

subject_name: Prosapogenin


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: UMLS:C5237339

subject_name: Indium In 111-DOTA-h11B6

object_name: Prostatic Cancer, Castration-Resistant


subject: UMLS:C5237339

object_name: metastatic neoplasm


subject: UMLS:C5237339

object_name: Embolism, Tumor


subject: UMLS:C5237339

object_name: Neoplasm Metastasis


subject: UMLS:C5237339

object_name: Metastatic Lesion


subject: UNII:7T1PY32ZPH

subject_name: Cirtuvivint

object_name: small cell lung carcinoma


subject: CHEBI:4757

object_name: heavy metal poisoning


subject: CHEBI:4735

subject_name: Edetic acid


subject: UMLS:C4079949

object_name: follicular lymphoma


subject: UMLS:C4287775

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4287775


subject: UMLS:C4287775

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4287775

object_name: non-Hodgkin lymphoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:AF75XOF6W3

subject_name: Relatlimab


subject: UNII:AF75XOF6W3


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: MESH:C000654964

subject_name: karonudib

object_name: leukemia


subject: MESH:C000654964

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:66586232

object_name: Wounds and Injuries


subject: PUBCHEM.COMPOUND:66586232

object_name: respiratory failure


subject: PUBCHEM.COMPOUND:66586232

object_name: Respiratory Failure, CTCAE


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:3614


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Nasopharyngeal squamous cell carcinoma stage II


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2012940

subject_name: tetrahydrocannabinol (medication)

object_name: anxiety


subject: UMLS:C2012940

object_name: anxiety disorder


subject: UMLS:C2012940

object_name: Anxiety symptoms


subject: UMLS:C2012940

object_name: Anxiety, CTCAE 3.0


subject: UMLS:C2012940

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C2012940

object_name: post operative nausea and vomiting


subject: CHEBI:66964

subject_name: Dronabinol


subject: CHEBI:66964


subject: CHEBI:66964


subject: CHEBI:66964


subject: CHEBI:66964


subject: CHEBI:7820

subject_name: Oxandrolone

object_name: Rupture of ligament of knee joint


subject: CHEBI:7773

subject_name: Ondansetron

object_name: cocaine abuse


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Locally Advanced Cutaneous Melanoma


subject: CHEBI:145371

object_name: Unresectable Cutaneous Melanoma


subject: CHEBI:145371

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:145371

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:145371

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:62932

subject_name: mycophenolate

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:8499

subject_name: Propranolol

object_name: Dysesthesia


subject: CHEBI:3374

subject_name: Capsaicin

object_name: Radiation Sickness


subject: CHEBI:3374

object_name: Neck Carcinoma


subject: CHEBI:3374

object_name: head and neck neoplasm


subject: CHEBI:3374

object_name: head and neck cancer


subject: MESH:C542292

object_name: cancer


subject: MESH:C542292

object_name: neoplasm


subject: MESH:C542292

object_name: ovarian cancer


subject: MESH:C542292

object_name: ovarian neoplasm


subject: MESH:C542292

object_name: ovarian carcinoma


subject: MESH:C542292

object_name: Childhood Solid Neoplasm


subject: MESH:C542292

object_name: Adult Solid Neoplasm


subject: MESH:C542292

object_name: Solid Neoplasm


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:30742

subject_name: macrogol

object_name: xerophthalmia


subject: CHEBI:30742

object_name: dry eye syndrome


subject: CHEBI:30742

object_name: Dry Eye Syndrome, CTCAE


subject: UMLS:C1655274

subject_name: Systane


subject: UMLS:C1655274


subject: UNII:3934EF02T7

subject_name: Piflufolastat F 18

object_name: Carcinoma breast stage IV


subject: UNII:3934EF02T7

object_name: Her2-receptor negative breast cancer


subject: CHEBI:2569

subject_name: Alfentanil

object_name: lung disorder


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:136044

subject_name: Fimasartan

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:129887057

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:129887057

object_name: alcohol dependence


subject: UNII:K6396E6G8G


subject: UNII:K6396E6G8G


subject: UNII:7P55415B0R


subject: UNII:7P55415B0R


subject: UMLS:C4723424

subject_name: Plenvu

object_name: colonic disease


subject: CHEBI:2569

object_name: Pain, Procedural


subject: UNII:8O74K609HN

subject_name: Obicetrapib

object_name: hyperlipoproteinemia


subject: UNII:8O74K609HN

object_name: genetic disease


subject: UNII:8O74K609HN

object_name: metabolic disease


subject: CHEBI:64816

object_name: acute leukemia


subject: CHEBI:64816

object_name: T-cell leukemia


subject: CHEBI:64816

object_name: Recurrent disease


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650

object_name: lymphoid leukemia


subject: CHEBI:17650


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:85993

subject_name: Palbociclib

object_name: lymphoblastic lymphoma


subject: CHEBI:85993

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:85993

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:85993


subject: CHEBI:85993

object_name: T-Cell Lymphoma


subject: CHEBI:85993

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:85993

object_name: Pre T-ALL


subject: CHEBI:85993


subject: CHEBI:85993


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: UMLS:C3267305

subject_name: Spirulina maxima preparation

object_name: cardiovascular disorder


subject: CHEBI:16899

subject_name: Mannitol

object_name: acute kidney failure


subject: CHEBI:16899

object_name: contrast-induced nephropathy


subject: CHEBI:16899

object_name: end stage renal failure


subject: CHEBI:16899

object_name: chronic kidney disease


subject: CHEBI:16899

object_name: Chronic uremia


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:47426


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:35854

object_name: COPD, severe early onset


subject: CHEBI:35854

object_name: chronic obstructive pulmonary disease


subject: UMLS:C1831903

object_name: Solid Neoplasm


subject: UMLS:C1831903

object_name: nephroblastoma


subject: UMLS:C1831903

object_name: Wilms tumor


subject: UMLS:C1831903

object_name: childhood kidney Wilms tumor


subject: UMLS:C1831903

object_name: adult germ cell tumor


subject: UMLS:C1831903

object_name: germ cell tumor


subject: UMLS:C1831903

object_name: childhood germ cell tumor


subject: UMLS:C1831903

object_name: Germ Cell Cancer


subject: UMLS:C1831903

object_name: carcinoma


subject: UMLS:C1831903

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C1831903

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C1831903

object_name: sarcoma


subject: UMLS:C1831903

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C1831903

object_name: soft tissue sarcoma


subject: UMLS:C1831903

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C1831903

object_name: rhabdomyosarcoma


subject: UMLS:C1831903

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C1831903

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C1831903

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C1831903

object_name: Ewing sarcoma


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Malignant pleural effusion


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: asthma


subject: CHEBI:41001

object_name: food allergy


subject: CHEBI:41001

object_name: rhinitis


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: PUBCHEM.COMPOUND:251912


subject: PUBCHEM.COMPOUND:251912


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C2698319


subject: UMLS:C2698319


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: UMLS:C0004886


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: PR:000002994


subject: PR:000002994


subject: CHEBI:139072

object_name: Suicidal ideation


subject: CHEBI:139072

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:194548

subject_name: Racepinephrine

object_name: Hemorrhage


subject: CHEBI:194548

object_name: Hemoptysis


subject: CHEBI:3223

subject_name: Buspirone

object_name: heroin dependence


subject: CHEBI:8871

subject_name: Risperidone


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Recurrent Thyroid Carcinoma


subject: UNII:15C2VL427D

object_name: Stage III Thyroid Gland Papillary Carcinoma AJCC v7


subject: UNII:15C2VL427D

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: UNII:15C2VL427D

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: UNII:15C2VL427D

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: UMLS:C3827168

object_name: Myelodysplasia


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE

object_name: bronchiectasis


subject: CHEBI:28177

subject_name: Theophylline


subject: UNII:15C2VL427D

object_name: Metastatic Cutaneous Melanoma


subject: UNII:15C2VL427D

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:15C2VL427D

object_name: iris melanoma


subject: UNII:15C2VL427D

object_name: Recurrent Uveal Melanoma


subject: UNII:15C2VL427D

object_name: ocular melanoma with extraocular extension


subject: UNII:15C2VL427D

object_name: medium/large size posterior uveal melanoma


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: cervical adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C5237721

subject_name: FAK1 Inhibitor IN10018


subject: CHEBI:600103

subject_name: daptomycin

object_name: Fatal Outcome


subject: CHEBI:41778

subject_name: Omigapil

object_name: muscular dystrophy


subject: CHEBI:41778

object_name: congenital muscular dystrophy


subject: MESH:C047053

subject_name: Theragran-M

object_name: AIDS


subject: MESH:C029401

subject_name: Ensure Plus


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Expressed Emotion


subject: UMLS:C0592155

subject_name: Syntocinon


subject: MESH:C558471

subject_name: Hizentra

object_name: staphylococcal infection


subject: MESH:C558471

object_name: streptococcal infection


subject: UMLS:C5447750

subject_name: Salt-inducible Kinase Inhibitor GRN-300

object_name: ovarian neoplasm


subject: GTOPDB:13796

subject_name: serplulimab

object_name: lung cancer


subject: GTOPDB:13796

object_name: lung neoplasm


subject: GTOPDB:13796

object_name: lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: UMLS:C4745029

subject_name: HLX 10


subject: UMLS:C4745029


subject: UMLS:C4745029


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Cervix carcinoma recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: Cervical carcinoma stage IVB


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVB Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVA Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Cervical carcinoma stage IVA


subject: PUBCHEM.COMPOUND:43805

object_name: cervical squamous cell carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: cervical adenosquamous carcinoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:135928

subject_name: Doripenem

object_name: septic shock


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: skin melanoma


subject: UMLS:C0359949

subject_name: epinephrine / lidocaine

object_name: Distal Radius Fractures


subject: UMLS:C0359949

object_name: Colles' Fracture


subject: UMLS:C0359949

object_name: Closed reduction of fracture and application of plaster cast


subject: UMLS:C0359949

object_name: Fracture Dislocation


subject: UMLS:C5782829

subject_name: ROPivacaine 0.2% injectable solution


subject: UMLS:C5782829


subject: UMLS:C5782829


subject: UMLS:C5782829


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Vaginal delivery (finding)


subject: CHEBI:3215

object_name: previous vaginal delivery (history)


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: UMLS:C2348252

subject_name: Diclofenac Sodium Gel

object_name: osteoarthritis, knee


subject: CHEMBL.COMPOUND:CHEMBL2108406

subject_name: EUCALYPTUS OIL

object_name: gingivitis


subject: CHEMBL.COMPOUND:CHEMBL2108406

object_name: Dental Plaque


subject: UMLS:C0540301

subject_name: C1 esterase inhibitor

object_name: Antibody-mediated rejection


subject: UMLS:C0009500

subject_name: Complement C1 Inactivator Proteins


subject: PUBCHEM.COMPOUND:152165

object_name: lower urinary tract symptom


subject: PUBCHEM.COMPOUND:152165

object_name: benign prostatic hyperplasia


subject: PUBCHEM.COMPOUND:152165

object_name: Hematuria, CTCAE


subject: PUBCHEM.COMPOUND:152165

object_name: Hematuria


subject: PUBCHEM.COMPOUND:152165

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:152165

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:152165

object_name: urinary bladder cancer


subject: PUBCHEM.COMPOUND:152165

object_name: childhood bladder carcinoma


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Abortion, 3 months


subject: CHEBI:188074

object_name: focal segmental glomerulosclerosis


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:8892


subject: UMLS:C0875967

subject_name: Avandia


subject: CHEBI:151315

subject_name: Heparin

object_name: cardiogenic shock


subject: KEGG.COMPOUND:C00374


subject: PR:000004153

subject_name: apolipoprotein C-IV

object_name: Chronic obstructive pulmonary disease of horses


subject: PR:000004153

object_name: COPD, severe early onset


subject: PR:000004153

object_name: chronic obstructive pulmonary disease


subject: CHEBI:30065

subject_name: Thioglycolate

object_name: Periorbital disorder


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Chest pain


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:5QS67N4551

subject_name: Conestat alfa

object_name: angioedema


subject: UNII:5QS67N4551

object_name: non-histaminic angioedema


subject: UNII:5QS67N4551

object_name: Angioneurotic edema, NEC in ICD9CM


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: transposition of the great arteries


subject: MESH:D000077203

object_name: congenitally corrected transposition of the great arteries


subject: MESH:D000077203

object_name: tetralogy of fallot


subject: MESH:D000077203

object_name: Systemic right ventricle


subject: MESH:D000077203

object_name: Single Ventricle Defect


subject: MESH:D000077203

object_name: Single ventricle


subject: UMLS:C0358321

subject_name: Immune Globulin (Human)

object_name: acute respiratory distress syndrome


subject: UMLS:C0358321

object_name: adult acute respiratory distress syndrome


subject: UMLS:C0358321


subject: UMLS:C3537193

subject_name: Human Immunoglobulin [EPC]


subject: UMLS:C3537193


subject: UMLS:C3537193


subject: CHEBI:17688

subject_name: Nicotine

object_name: constipation, impaction, and bowel obstruction


subject: CHEBI:17688

object_name: psychosocial effects of cancer and its treatment


subject: CHEBI:17688

object_name: Anorexia


subject: CHEBI:17688

object_name: Anorexia, CTCAE


subject: CHEBI:17688

object_name: Anorexia symptom


subject: UNII:YGR6AY6YL8

object_name: systemic sclerosis


subject: UMLS:C5853436


subject: CHEBI:174615

object_name: alymphoplasia; thymic


subject: CHEBI:28901

subject_name: Busulfan


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Decompensated cirrhosis of liver


subject: CHEBI:231347

subject_name: Triapine

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:231347

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:231347

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:231347

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:231347

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:231347

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:231347

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:231347

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Overweight


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Physical disability


subject: CHEBI:89324

object_name: physical disability (history)


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: MESH:D002136

subject_name: Calcium, Dietary


subject: MESH:D002136


subject: MESH:D002136

object_name: Paresis


subject: MESH:D002136

object_name: Muscle weakness


subject: MESH:D002136

object_name: Frailty


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: CHEBI:27470

subject_name: Folic acid

object_name: Adverse effect of other general anesthetics


subject: MESH:D010919

subject_name: Placebos


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Pick Complex


subject: CHEBI:6888

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:6888

object_name: frontotemporal dementia


subject: CHEBI:6888

object_name: Pick disease


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Abnormal menstrual cycle


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:95165

object_name: fallopian tube carcinoma


subject: CHEBI:95165

object_name: fallopian tube cancer


subject: CHEBI:95165

object_name: peritoneum cancer


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: UMLS:C5391459

subject_name: ChAdOx1 MERS

object_name: Middle East respiratory syndrome


subject: GTOPDB:11592

subject_name: evorpacept

object_name: urothelial carcinoma


subject: GTOPDB:11592

object_name: transitional cell carcinoma


subject: GTOPDB:11592

object_name: bladder tumor


subject: GTOPDB:11592

object_name: urinary bladder carcinoma


subject: GTOPDB:11592

object_name: urinary bladder cancer


subject: GTOPDB:11592

object_name: childhood bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297880

subject_name: EVORPACEPT


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: heart failure; with decompensation


subject: CHEBI:2922

subject_name: Auranofin

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:2922

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:2922

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:2922

object_name: Small cell lung cancer recurrent


subject: CHEBI:2922

object_name: Small cell lung cancer extensive stage


subject: CHEBI:2922

object_name: squamous cell lung carcinoma


subject: CHEBI:2922

object_name: lung adenocarcinoma


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:17924

subject_name: Sorbitol

object_name: Surgical procedure finding


subject: CHEBI:17924

object_name: Constipation


subject: CHEBI:17924

object_name: Constipation, CTCAE


subject: CHEBI:17924

object_name: ileus


subject: CHEBI:17924

object_name: Ileus, CTCAE


subject: UMLS:C0771180

subject_name: dextrose 15 % in water

object_name: frozen shoulder


subject: UMLS:C0771180

object_name: bursitis


subject: CHEBI:16374

subject_name: Menatetrenone

object_name: postmenopausal osteoporosis


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: CHEBI:90942

subject_name: Ixazomib


subject: UMLS:C3273938

subject_name: CGTG 102

object_name: neoplasm


subject: UMLS:C3273938

object_name: Solid Neoplasm


subject: DRUGBANK:DB17173


subject: DRUGBANK:DB17173


subject: CHEMBL.COMPOUND:CHEMBL1743006

subject_name: DALOTUZUMAB

object_name: Childhood Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743006

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743006

object_name: plasma cell myeloma


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: UMLS:C2987605


subject: UMLS:C2987605


subject: UMLS:C5139837

subject_name: Pegadricase

object_name: Chronic gouty arthritis


subject: UMLS:C5814625


subject: UMLS:C4764320

subject_name: Bupropion HCl Extended Release

object_name: seasonal affective disorder


subject: UMLS:C4527230

subject_name: Zirconium (89Zr) crefmirlimab berdoxam

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4527230

object_name: clear cell renal carcinoma


subject: UMLS:C4527230

object_name: renal cell adenocarcinoma


subject: UMLS:C4527230

object_name: renal cell carcinoma


subject: UMLS:C4527230

object_name: melanoma


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: Postoperative Complications


subject: CHEBI:184693

object_name: hypotension


subject: CHEBI:184693

object_name: Hypotension, CTCAE


subject: CHEBI:7773

subject_name: Ondansetron


subject: UMLS:C5908044

subject_name: Autologous PSMA-inducible Anti-CA9 CAR T-cells AB-2100

object_name: Recurrence


subject: UMLS:C5908044

object_name: Recurrent Malignant Neoplasm


subject: UMLS:C5908044

object_name: Recurrent disease


subject: UMLS:C5908044

object_name: Recurrent tumor


subject: CHEBI:34605

object_name: Alzheimer disease


subject: CHEBI:34605

object_name: Presenile dementia


subject: CHEBI:34605

object_name: dementia


subject: PUBCHEM.COMPOUND:56841751

subject_name: Epidermal Growth Factor

object_name: temporomandibular joint disorder


subject: PR:000006928

subject_name: pre-pro-epidermal growth factor


subject: PR:000060269

subject_name: epidermal growth factor


subject: CHEBI:2663

subject_name: Amiodarone

object_name: cardiac; dysrhythmia, postoperative


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:32599


subject: CHEBI:8428

subject_name: Procainamide


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: obstructive lung disease


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:174379

object_name: dental caries


subject: CHEBI:174379

object_name: Caries (morphologic abnormality)


subject: CHEBI:174379

object_name: Adverse effects


subject: UMLS:C0770612

subject_name: licorice root extract


subject: UMLS:C0770612


subject: UMLS:C0770612


subject: UMLS:C0086555

subject_name: licorice


subject: UMLS:C0086555


subject: UMLS:C0086555


subject: CHEBI:67271

object_name: Renal cell carcinoma recurrent


subject: CHEBI:67271

object_name: Metastatic Kidney Carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:266052

subject_name: Vitamin

object_name: benign neoplasm of retina


subject: PUBCHEM.COMPOUND:266052

object_name: retinal cancer


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: UMLS:C0556112

subject_name: Mineral supplements


subject: UMLS:C0556112


subject: GTOPDB:6781

subject_name: tositumomab

object_name: mantle cell lymphoma


subject: UNII:0343IGH41U

subject_name: TOSITUMOMAB


subject: UMLS:C0879399


subject: CHEBI:60791

subject_name: Xylocard

object_name: cerebral palsy


subject: CHEBI:6456

subject_name: Lidocaine


subject: UMLS:C0054946

subject_name: CD20 Antigens

object_name: B-Cell Leukemia


subject: PR:000001289

subject_name: membrane-spanning 4-domains subfamily A member 1


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Refractory Colorectal Adenocarcinoma


subject: UMLS:C3641087

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C3641087

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEMBL.COMPOUND:CHEMBL1743042

subject_name: MOTAVIZUMAB

object_name: respiratory syncytial virus infectious disease


subject: CHEBI:114785

subject_name: Erlotinib

object_name: cervical squamous cell carcinoma


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Ventricular Remodeling


subject: MESH:D000077203

object_name: Ventricular Dysfunction


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C3542461


subject: UNII:O4BT6C02M2

subject_name: Zetomipzomib

object_name: autoimmune thrombocytopenia


subject: UNII:O4BT6C02M2

object_name: thrombocytopenia due to immune destruction


subject: UNII:O4BT6C02M2

object_name: autoimmune thrombocytopenic purpura


subject: UNII:O4BT6C02M2

object_name: autoimmune hemolytic anemia


subject: GTOPDB:12900

subject_name: pozelimab

object_name: acquired idiopathic inflammatory myopathy


subject: GTOPDB:12900

object_name: idiopathic inflammatory myopathy


subject: UNII:0JJ21K6L2I

subject_name: Pozelimab


subject: UNII:0JJ21K6L2I


subject: UNII:S66Z65E10T

subject_name: CEMDISIRAN


subject: UNII:S66Z65E10T


subject: UMLS:C0078221

subject_name: typhoid Vi polysaccharide vaccine, S typhi Ty2 strain

object_name: post-traumatic stress disorder


subject: UNII:8A7F670F2Y

subject_name: Sacrosidase


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:151315

subject_name: Heparin

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:151315

object_name: ISS Stage I Plasma Cell Myeloma


subject: CHEBI:151315

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:151315

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:151315

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:151315

object_name: DS Stage III Plasma Cell Myeloma


subject: GTOPDB:6803

subject_name: dalteparin


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: adult acute myeloid leukemia


subject: UNII:7D0YB67S97

object_name: childhood acute myeloid leukemia


subject: UNII:7D0YB67S97

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:125427

object_name: disorders of calcium and bone metabolism


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG


subject: CHEBI:7931

subject_name: Paricalcitol


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: autoimmune hemolytic anemia, warm type


subject: CHEBI:31932

subject_name: olmesartan

object_name: heart failure


subject: UMLS:C5557489

subject_name: TLR 7/8 Antagonist M5049

object_name: cutaneous lupus erythematosus


subject: UMLS:C5557489

object_name: EXCESS LMW-DNA


subject: MESH:C000615779

object_name: Aflatoxin Poisoning


subject: MESH:C000615779

object_name: aflatoxicosis


subject: CHEBI:4856

subject_name: Esmolol

object_name: diabetes mellitus


subject: CHEBI:4856

object_name: Cirrhosis


subject: CHEBI:4856

object_name: liver cirrhosis


subject: CHEBI:4856

object_name: oncologic disorders


subject: UMLS:C0915830

object_name: Myelodysplasia


subject: UMLS:C0915830

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0915830

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0915830

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0962969

subject_name: RAD 001


subject: UMLS:C0962969


subject: UMLS:C0962969


subject: UMLS:C0962969


subject: UMLS:C0962969

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:17596

subject_name: Inosine

object_name: Coronavinae infectious disease


subject: CHEBI:17596

object_name: viral pneumonia


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:16411


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: diabetes insipidus


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: CHEBI:15365

subject_name: Aspirin

object_name: placental insufficiency


subject: CHEBI:6931

subject_name: Midazolam

object_name: Increased reactive oxygen species production


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Recurrent ovarian cancer


subject: MESH:C487773

subject_name: trans-sodium crocetinate

object_name: intermittent vascular claudication


subject: CHEBI:63639

subject_name: tetrasulfocyanine


subject: CHEBI:16031

subject_name: Indoleacetamide


subject: PR:000016240

subject_name: calcineurin B homologous protein 3


subject: PR:000016708

subject_name: hamartin


subject: PR:000014926

subject_name: solute carrier family 12 member 3


subject: UNII:IZY9ZSI6FI

subject_name: ZILOVERTAMAB VEDOTIN


subject: UNII:IZY9ZSI6FI

object_name: acute myeloid leukemia


subject: UNII:IZY9ZSI6FI

object_name: marginal zone lymphoma


subject: UNII:IZY9ZSI6FI

object_name: MALT lymphoma


subject: UNII:IZY9ZSI6FI

object_name: lymphoplasmacytic lymphoma


subject: UNII:IZY9ZSI6FI

object_name: Waldenstrom macroglobulinemia


subject: UNII:IZY9ZSI6FI

object_name: T-Cell Lymphoma


subject: UNII:IZY9ZSI6FI

object_name: acute lymphoblastic leukemia


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: CHEBI:119915

subject_name: Fentanyl

object_name: hypospadias


subject: CHEBI:119915

object_name: Penile hypospadias


subject: CHEBI:17925

subject_name: alpha-D-glucose


subject: CHEBI:17925


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17634

subject_name: D-glucose


subject: CHEBI:17634


subject: CHEBI:17234


subject: CHEBI:17234


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:7514

subject_name: Neostigmine


subject: CHEBI:7514


subject: CHEBI:57858

subject_name: atropinium


subject: CHEBI:57858


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:92712


subject: CHEBI:91541


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: UMLS:C1161352


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Burn injury


subject: CHEBI:5931

subject_name: insulin human


subject: UMLS:C0302918

subject_name: Stable isotope


subject: CHEBI:37845

subject_name: growth hormone

object_name: short bowel syndrome


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: urinary tract infection


subject: CHEBI:150712

object_name: bacterial urinary tract infection


subject: CHEBI:150712

object_name: Urinary Tract Infection, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:57858

object_name: Morphine adverse reaction


subject: CHEBI:92712


subject: CHEBI:91541


subject: UMLS:C1161352


subject: CHEBI:47781

subject_name: Desipramine

object_name: chronic pain (diagnosis)


subject: CHEBI:47781

object_name: Chronic pain


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C1518041

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C1518041

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C1518041

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C1518041

object_name: castration-resistant prostate carcinoma


subject: UMLS:C1518041

object_name: Prostate cancer recurrent


subject: UMLS:C1518041

object_name: Prostatic Cancer, Castration-Resistant


subject: UMLS:C4721408

subject_name: Substance with receptor antagonist mechanism of action (substance)


subject: UMLS:C4721408


subject: UMLS:C4721408


subject: UMLS:C4721408


subject: UMLS:C4721408


subject: UMLS:C4721408


subject: UMLS:C4721408

object_name: metastatic prostate carcinoma


subject: UMLS:C4721408


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: squamous cell lung carcinoma


subject: UNII:M89N0Q7EQR

object_name: female reproductive organ cancer


subject: UNII:M89N0Q7EQR

object_name: adenosquamous lung carcinoma


subject: UNII:M89N0Q7EQR

object_name: endometrial cancer


subject: UNII:M89N0Q7EQR

object_name: uterine corpus cancer


subject: UNII:M89N0Q7EQR

object_name: endometrial carcinoma


subject: UNII:M89N0Q7EQR

object_name: malignant epithelial tumor of ovary


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985

object_name: lung adenocarcinoma


subject: GTOPDB:4985

object_name: cholangiocarcinoma


subject: GTOPDB:4985


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: iron deficiency anemia


subject: UMLS:C5814279

object_name: hepatorenal syndrome


subject: UMLS:C5814279

object_name: Cirrhosis


subject: UMLS:C5814279

object_name: liver cirrhosis


subject: UMLS:C5814279

object_name: Ascites


subject: UMLS:C5814279

object_name: Ascites, CTCAE


subject: UMLS:C5814279

object_name: acute kidney failure


subject: UMLS:C5814279

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C5446566

subject_name: B-cell Lymphoma-2 Inhibitor BGB-11417

object_name: mast cell leukemia


subject: UMLS:C5446566

object_name: Multiple cutaneous leiomyomas


subject: UMLS:C4727614

object_name: mantle cell lymphoma


subject: UMLS:C4727614


subject: UMLS:C4727614


subject: UMLS:C0054946

subject_name: CD20 Antigens


subject: UMLS:C0054946


subject: UMLS:C0054946


subject: PR:000001289

subject_name: membrane-spanning 4-domains subfamily A member 1


subject: PR:000001289


subject: PR:000001289


subject: UMLS:C5399992

object_name: myelodysplastic syndrome with excess blasts-2


subject: CHEBI:221624

subject_name: BAA


subject: CHEBI:30006

subject_name: L-leucine residue


subject: CHEBI:25017

subject_name: leucine


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Stage III Gallbladder Cancer AJCC v7


subject: UNII:D99YVK4L0X

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: UNII:D99YVK4L0X

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: UNII:D99YVK4L0X

object_name: Stage IV Gallbladder Cancer AJCC v7


subject: UNII:D99YVK4L0X

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: UNII:D99YVK4L0X

object_name: stage IVA gallbladder cancer


subject: UNII:D99YVK4L0X

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: UNII:D99YVK4L0X

object_name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


subject: UNII:D99YVK4L0X

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7


subject: UNII:D99YVK4L0X

object_name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


subject: UNII:D99YVK4L0X

object_name: Unresectable Gallbladder Carcinoma


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1330606

subject_name: Wellbutrin XL

object_name: Childhood Breast Carcinoma


subject: UMLS:C1330606

object_name: breast carcinoma


subject: UMLS:C1330606

object_name: breast cancer


subject: UMLS:C1330606

object_name: endogenous depression


subject: UMLS:C1330606

object_name: major depressive disorder


subject: MESH:D065346

subject_name: Lubricant Eye Drops

object_name: dry eye syndrome


subject: CHEBI:75984

subject_name: Flecainide

object_name: Multiple premature ventricular complexes


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733

object_name: Premature ventricular contraction


subject: CHEBI:63622

subject_name: Sotalol


subject: CHEBI:63622


subject: UMLS:C5206815

object_name: gastric cancer


subject: UNII:7CND0TX59N

subject_name: Potassium octanoate

object_name: Small cell lung cancer recurrent


subject: CHEBI:25646

subject_name: octanoate


subject: CHEBI:28837

subject_name: Caprylic acid


subject: UNII:P6R62377KV

subject_name: TETRACYCLINE HYDROCHLORIDE

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:54685734

subject_name: Epitetracycline


subject: CHEBI:35006

subject_name: Tetracycline hydrochloride


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: UNII:B669M62ELP

subject_name: MRX-I

object_name: pulmonary tuberculosis


subject: UNII:B669M62ELP

object_name: rifampicin-resistant tuberculosis


subject: PUBCHEM.COMPOUND:11756905

subject_name: Delamanid


subject: CHEBI:125427

object_name: glomerulonephritis


subject: CHEBI:125427

object_name: Autoimmunity


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:4672

subject_name: Docetaxel

object_name: estrogen-receptor positive breast cancer


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UMLS:C5239903

subject_name: Phesgo

object_name: Carcinoma breast stage IV


subject: UMLS:C5239903

object_name: Malignant neoplasm of female breast


subject: UMLS:C5239903

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C5239903

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5239903

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5239903


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C4287766


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: aneurysm


subject: UMLS:C3714803

object_name: cerebrovascular disorder


subject: UMLS:C3714803

object_name: heart disorder


subject: UMLS:C3714803

object_name: myocardial infarction


subject: UMLS:C3714803

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C3714803

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C3714803

object_name: myocardial ischemia


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:30956

subject_name: trichloroacetic acid

object_name: Postinflammatory hyperpigmentation


subject: UMLS:C3536819

subject_name: Tricyclic Antidepressant [EPC]


subject: UNII:2WTV10SIKH

subject_name: Mitapivat

object_name: Moderate Hepatic Insufficiency


subject: UMLS:C2347742

object_name: cancer


subject: UMLS:C2347742

object_name: neoplasm


subject: UMLS:C2347742

object_name: colorectal cancer


subject: UMLS:C2347742

object_name: colorectal carcinoma


subject: UMLS:C2347742

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2347742

object_name: thyroid gland papillary carcinoma


subject: UMLS:C2347742

object_name: melanoma


subject: CHEBI:4975

subject_name: Famotidine


subject: CHEBI:4975


subject: CHEBI:4975


subject: CHEBI:4975


subject: CHEBI:4975


subject: CHEBI:4975


subject: CHEBI:4975


subject: UNII:1VI94C980K

object_name: type 2 diabetes mellitus


subject: UMLS:C4079835


subject: UMLS:C4045572

object_name: traumatic encephalopathy


subject: UMLS:C4045572

object_name: traumatic brain injury


subject: UMLS:C0003299

subject_name: Antiepileptic Agents


subject: UMLS:C0003299


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: neuroendocrine neoplasm


subject: UNII:28X28X9OKV

object_name: lung neuroendocrine neoplasm


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:231683

subject_name: Anakinra

object_name: Heart failure with normal ejection fraction


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: DRUGBANK:DB05014

object_name: ovarian cancer


subject: DRUGBANK:DB05014

object_name: ovarian neoplasm


subject: DRUGBANK:DB05014

object_name: ovarian carcinoma


subject: CHEBI:601027

subject_name: Aliskiren

object_name: diastolic heart failure


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Kala-Azar


subject: CHEBI:52717

subject_name: Bortezomib

object_name: plasmablastic lymphoma


subject: CHEBI:52717

object_name: large-cell immunoblastic lymphoma


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan

object_name: Ewing sarcoma


subject: CHEBI:7476

subject_name: Naproxen

object_name: Compulsion


subject: CHEBI:7476

object_name: PANDAS


subject: CHEBI:7476

object_name: Autoimmunity


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: adrenoleukodystrophy


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:41139

subject_name: BETAINE

object_name: peroxisome biogenesis disorder


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: HIV infection


subject: UMLS:C4053601


subject: CHEBI:29947

subject_name: glycine residue

object_name: Alzheimer disease type 1


subject: CHEBI:29947

object_name: Alzheimer disease


subject: CHEBI:15428

subject_name: Glycine


subject: CHEBI:15428


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:3423

subject_name: Carmustine

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: CHEBI:3423

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: CHEBI:3423

object_name: ALK-negative anaplastic large cell lymphoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UNII:RZ22DI43TP

subject_name: PROTHROMBIN COMPLEX CONCENTRATE

object_name: heart valve disorder


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: UMLS:C4048712

subject_name: factor IX complex


subject: CHEBI:166975

subject_name: soybean oil

object_name: Premature birth


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: CHEBI:18059

subject_name: lipid

object_name: Premature infant


subject: CHEBI:18059


subject: MESH:D008055

subject_name: Lipids


subject: MESH:D008055


subject: CHEBI:16664

subject_name: Albendazole

object_name: diarrhea


subject: CHEBI:16664

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:16664

object_name: Diarrhea, CTCAE


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Laryngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: salivary gland squamous cell carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Laryngeal verrucous carcinoma recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Salivary Gland Cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: tongue carcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423

object_name: tongue cancer


subject: CHEBI:44423


subject: UNII:690VN2L7TK

subject_name: Unithiol

object_name: Wilson disease


subject: CHEBI:888

subject_name: unithiol


subject: CHEBI:63623

subject_name: Succimer


subject: PR:000022455

subject_name: anaerobic dimethyl sulfoxide reductase chain A


subject: UniProtKB:P18775

subject_name: DMSA_ECOLI Dimethyl sulfoxide reductase DmsA (sprot)


subject: UMLS:C3714633

subject_name: Penicillamine Drug Class


subject: CHEBI:7959

subject_name: Penicillamine


subject: UMLS:C0025536

subject_name: Metalcaptase


subject: CHEBI:29708

subject_name: Zinc gluconate


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: UMLS:C3851199

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:18319735

object_name: Pulmonary Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:18319735

object_name: heart failure


subject: PUBCHEM.COMPOUND:18319735

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:18319735

object_name: Pulmonary vascular resistance abnormality


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Myeloproliferative Chronic Myelomonocytic Leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:567361

subject_name: Cladribine


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:133021

subject_name: Venetoclax


subject: UNII:2R985002CT

subject_name: Mexidol

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UNII:2R985002CT

object_name: Anxiety disorders and symptoms


subject: UMLS:C0128329

subject_name: mexidol


subject: UMLS:C0128329


subject: CHEBI:151315

subject_name: Heparin

object_name: traumatic brain injury


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: traumatic encephalopathy


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: CHEBI:53221

subject_name: poly(ethyl methacrylate) macromolecule

object_name: Leg Ulcer


subject: CHEBI:53221

object_name: Varicose Ulcer


subject: CHEBI:53221

object_name: Reflux


subject: CHEBI:53221

object_name: Heartburn


subject: CHEBI:53221

object_name: Varicose veins of lower extremity


subject: CHEBI:53221

object_name: varicose ulcer


subject: CHEBI:53221

object_name: Venous reflux


subject: CHEBI:53221

object_name: Venous stasis ulcer of leg


subject: CHEBI:61371

subject_name: poly(ethyl methacrylate) polymer


subject: CHEBI:61371


subject: CHEBI:61371


subject: CHEBI:61371


subject: CHEBI:61371


subject: CHEBI:61371


subject: CHEBI:61371


subject: CHEBI:61371


subject: UniProtKB:P52651

subject_name: RHOX5_MOUSE Homeobox protein Rhox5 (sprot)


subject: UniProtKB:P52651


subject: UniProtKB:P52651


subject: UniProtKB:P52651


subject: UniProtKB:P52651


subject: UniProtKB:P52651


subject: UniProtKB:P52651


subject: UniProtKB:P52651


subject: PR:000014397

subject_name: homeobox protein Rhox5


subject: PR:000014397


subject: PR:000014397


subject: PR:000014397


subject: PR:000014397


subject: PR:000014397


subject: PR:000014397


subject: PR:000014397


subject: PR:000001890


subject: PR:000001890


subject: PR:000001890


subject: PR:000001890


subject: PR:000001890


subject: PR:000001890


subject: PR:000001890


subject: PR:000001890


subject: UNII:7N13IK9LNH

object_name: Refractory Ewing Sarcoma


subject: UNII:7N13IK9LNH

object_name: Refractory Lymphoma


subject: UNII:7N13IK9LNH

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:7N13IK9LNH

object_name: Refractory Alveolar Rhabdomyosarcoma


subject: UNII:7N13IK9LNH

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:7N13IK9LNH

object_name: Recurrent Alveolar Rhabdomyosarcoma


subject: UNII:7N13IK9LNH

object_name: Ewing's sarcoma recurrent


subject: UNII:7N13IK9LNH

object_name: Recurrent Lymphoma


subject: DRUGBANK:DB19041

subject_name: Elimusertib


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: CHEBI:9168

subject_name: Sirolimus

object_name: lymphoblastic lymphoma


subject: CHEBI:9168

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: adult T-cell leukemia/lymphoma


subject: CHEBI:9168

object_name: Adult Burkitt Lymphoma


subject: CHEBI:91872

object_name: intravascular large B-cell lymphoma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Diffuse large B-cell lymphoma, unclassifiable, NOS


subject: CHEBI:231614


subject: CHEBI:231614

object_name: T-cell/histiocyte rich large B cell lymphoma


subject: CHEBI:231614

object_name: CD20 Positive


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A

object_name: primary mediastinal large B-cell lymphoma


subject: UNII:T5IRO3534A

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:T5IRO3534A

object_name: B-cell neoplasm


subject: UNII:T5IRO3534A

object_name: Aggressive Non-Hodgkin Lymphoma


subject: UNII:T5IRO3534A

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:47097

subject_name: Lonafarnib

object_name: non-small cell lung carcinoma


subject: UMLS:C1517935

subject_name: Sarasar


subject: UMLS:C1517935

object_name: Neoplasm Metastasis


subject: CHEBI:5132

subject_name: Flutamide

object_name: ovarian cancer


subject: CHEBI:5132

object_name: ovarian neoplasm


subject: CHEBI:5132

object_name: ovarian carcinoma


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Myelodysplasia


subject: UNII:1C6V77QF41


subject: UNII:1C6V77QF41

object_name: leukemia


subject: UNII:1C6V77QF41

object_name: childhood leukemia


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: low grade glioma


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Metastatic malignant neoplasm to liver


subject: UNII:KWM30LC1JM

object_name: diabetic kidney disease


subject: UMLS:C2930769


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: eosinophilic esophagitis


subject: UNII:2P471X1Z11

object_name: Eosinophilic infiltration of the esophagus


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:49900

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:49900

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:49900

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:49900

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:49900

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:49900

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:49900

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:49900

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:49900

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:49900

object_name: adult acute monocytic leukemia


subject: CHEBI:49900

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:49900

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:49900

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:49900

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Eisenmenger syndrome


subject: PUBCHEM.COMPOUND:4479094

subject_name: Doxercalciferol

object_name: kidney failure


subject: PUBCHEM.COMPOUND:4479094

object_name: Renal Failure, CTCAE


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Renal transplant rejection


subject: CHEBI:74705

object_name: Renal transplant failure


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: GTOPDB:13361

subject_name: suvratoxumab

object_name: staphylococcus aureus infection


subject: GTOPDB:13361

object_name: ventilator-associated pneumonia


subject: UNII:4L1997J4DF


subject: UNII:4L1997J4DF


subject: UMLS:C4726796


subject: UMLS:C4726796


subject: UMLS:C3813201

subject_name: Oral Rehydration Solution OS-1

object_name: pneumonia childhood


subject: UMLS:C0078516

subject_name: World Health Organization oral rehydration solution


subject: UMLS:C1443923

subject_name: Oral rehydration solution


subject: UMLS:C3831455

object_name: Cushing syndrome


subject: UMLS:C3831455

object_name: adrenal gland hyperfunction


subject: UMLS:C3831455

object_name: hyperaldosteronism


subject: CHEBI:64073

object_name: Heart Failure, CTCAE


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Adverse effects


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: opioid use


subject: UMLS:C1527137

object_name: Post-Operative Pain


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Abnormality of the urethra


subject: CHEBI:6456

object_name: Cystocele


subject: CHEBI:6456

object_name: Pelvic Floor Disorders


subject: CHEBI:6456

object_name: pelvic organ prolapse


subject: CHEBI:6456

object_name: Uterine prolapse without mention of vaginal wall prolapse


subject: CHEBI:6456

object_name: Uterine prolapse


subject: CHEBI:6456

object_name: pelvic organ prolapse, susceptibility to


subject: UMLS:C0034131

subject_name: Tubersol

object_name: Human Papilloma Virus, Female


subject: UMLS:C0034131

object_name: Human Papilloma Virus, Male


subject: UMLS:C0034131

object_name: Infection


subject: UMLS:C0034131

object_name: Infection of musculoskeletal system


subject: CHEBI:83766

subject_name: Olaparib

object_name: bone cancer


subject: CHEBI:83766

object_name: bone neoplasm


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: CHEBI:75431

subject_name: ghrelin

object_name: peripheral vascular disease


subject: CHEBI:75431

object_name: peripheral arterial disease


subject: DRUGBANK:DB11895

subject_name: Lenomorelin


subject: DRUGBANK:DB11895


subject: UMLS:C0911014


subject: UMLS:C0911014


subject: UMLS:C2348442

object_name: carcinoma


subject: PUBCHEM.COMPOUND:268

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:149504

object_name: Albuminuria


subject: CHEBI:6541

subject_name: Losartan


subject: UMLS:C4329339

object_name: biliary tract neoplasm


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen


subject: UMLS:C3534685

subject_name: Injection, aflibercept, 1 mg administered

object_name: diabetic retinopathy


subject: UMLS:C5203181

subject_name: Aflibercept Liquid Injection


subject: CHEBI:52717

subject_name: Bortezomib

object_name: metastatic neoplasm


subject: CHEBI:52717

object_name: Metastatic Lesion


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: UMLS:C0242937

subject_name: Analgesics, Non-Narcotic

object_name: opioid use


subject: UMLS:C0242937

object_name: heart; surgery, heart, functional disturbance as result


subject: UMLS:C4053707

subject_name: Glifage

object_name: Nutritional and Metabolic Diseases


subject: CHEBI:6801

subject_name: Metformin


subject: UMLS:C4744839

subject_name: Pharmacological Ascorbate

object_name: Enterocutaneous fistula


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:15407

subject_name: Ephedrine

object_name: congenital myasthenic syndrome


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Nodal marginal zone B-cell lymphoma refractory


subject: CHEBI:63791

object_name: Splenic marginal zone lymphoma refractory


subject: CHEBI:63791

object_name: Nodal marginal zone B-cell lymphoma recurrent


subject: CHEBI:63791

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) refractory


subject: CHEBI:63791


subject: CHEBI:63791

object_name: Splenic marginal zone lymphoma recurrent


subject: CHEBI:63791

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) recurrent


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: Mantle cell lymphoma refractory


subject: UNII:U59UGK3IPC

object_name: Mantle cell lymphoma recurrent


subject: UNII:U59UGK3IPC

object_name: B-cell lymphoma refractory


subject: UNII:U59UGK3IPC

object_name: B-cell lymphoma recurrent


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC

object_name: Marginal zone lymphoma refractory


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC

object_name: Refractory Grade 1 Follicular Lymphoma


subject: UNII:U59UGK3IPC

object_name: Refractory Grade 2 Follicular Lymphoma


subject: UNII:U59UGK3IPC

object_name: Refractory Grade 3a Follicular Lymphoma


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC

object_name: Marginal zone lymphoma recurrent


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC


subject: UNII:U59UGK3IPC

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:U59UGK3IPC

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:U59UGK3IPC

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225

object_name: Nodal marginal zone B-cell lymphoma refractory


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225

object_name: Splenic marginal zone lymphoma refractory


subject: UMLS:C2934225


subject: UMLS:C2934225

object_name: Nodal marginal zone B-cell lymphoma recurrent


subject: UMLS:C2934225

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) refractory


subject: UMLS:C2934225

object_name: Splenic marginal zone lymphoma recurrent


subject: UMLS:C2934225

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) recurrent


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UNII:38073MQB2A

subject_name: Umbralisib

object_name: Mantle cell lymphoma refractory


subject: UNII:38073MQB2A

object_name: Mantle cell lymphoma recurrent


subject: UNII:38073MQB2A

object_name: B-cell lymphoma refractory


subject: UNII:38073MQB2A

object_name: B-cell lymphoma recurrent


subject: UNII:38073MQB2A


subject: UNII:38073MQB2A

object_name: Marginal zone lymphoma refractory


subject: UNII:38073MQB2A


subject: UNII:38073MQB2A

object_name: Refractory Grade 1 Follicular Lymphoma


subject: UNII:38073MQB2A

object_name: Refractory Grade 2 Follicular Lymphoma


subject: UNII:38073MQB2A

object_name: Refractory Grade 3a Follicular Lymphoma


subject: UNII:38073MQB2A


subject: UNII:38073MQB2A

object_name: Marginal zone lymphoma recurrent


subject: UNII:38073MQB2A


subject: UNII:38073MQB2A


subject: UNII:38073MQB2A


subject: UNII:38073MQB2A


subject: UNII:38073MQB2A

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:38073MQB2A

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:38073MQB2A

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: CHEBI:37845

subject_name: growth hormone

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: CHEBI:85170

subject_name: nintedanib esylate

object_name: interstitial lung disease


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Iron deficiency


subject: CHEBI:36005

object_name: iron deficiency anemia


subject: CHEBI:36005

object_name: anemia


subject: CHEBI:36005

object_name: Anemia, CTCAE


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: UMLS:C1709066

object_name: follicular lymphoma


subject: CHEBI:36791

subject_name: Escitalopram

object_name: pervasive developmental disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:190008

subject_name: Tianeptine


subject: CHEBI:190008

object_name: autism


subject: CHEBI:190008

object_name: autism spectrum disorder


subject: CHEBI:141213

subject_name: Isoxaflutole

object_name: Recurrent oral herpes


subject: CHEBI:7549

subject_name: L-NAME

object_name: orthostatic hypotension


subject: UMLS:C0083536

subject_name: NG-Nitroarginine Methyl Ester


subject: CHEBI:6413

subject_name: Letrozole

object_name: Abortion complete


subject: CHEBI:63610

subject_name: Misoprostol


subject: CHEBI:50692

subject_name: Mifepristone


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Pregnant


subject: CHEBI:50861

subject_name: Treprostinil

object_name: scleroderma


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:68646

object_name: Recurrent Glioblastoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Cancer of kidney and renal pelvis


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:32139

object_name: Metabolic alkalosis


subject: UMLS:C5848865

subject_name: Cell Therapy [APC]

object_name: spinal cord injury


subject: UMLS:C1683281

object_name: Childhood Neuroblastoma


subject: UMLS:C1683281

object_name: neuroblastoma


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: mood disorder


subject: UMLS:C5908034

subject_name: Anti-B7-H4/Anti-4-1BB Bispecific Antibody ABL103

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:4670

subject_name: Dobutamine

object_name: Complications of Diabetes Mellitus


subject: UMLS:C1099662

object_name: Carcinoma breast stage IV


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Still Disease


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: heart failure


subject: PUBCHEM.COMPOUND:9831414

object_name: Heart Failure, CTCAE


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: CHEBI:8378

subject_name: Prednisolone

object_name: adrenocortical insufficiency


subject: CHEBI:8378

object_name: Adrenal Insufficiency, CTCAE


subject: GTOPDB:13785

subject_name: stapokibart

object_name: primary cutaneous amyloidosis


subject: CHEMBL.COMPOUND:CHEMBL5095324

subject_name: STAPOKIBART


subject: UMLS:C5706513

subject_name: Stapokibart


subject: CHEMBL.COMPOUND:CHEMBL3544953

object_name: Neurogenic bladder


subject: CHEMBL.COMPOUND:CHEMBL3544953

object_name: Neurogenic Urinary Bladder, Spastic


subject: CHEMBL.COMPOUND:CHEMBL3544953

object_name: Neurogenic Urinary Bladder, Uninhibited


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: cardiogenic shock


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine

object_name: melanoma


subject: CHEBI:64312

subject_name: Memantine

object_name: Frontotemporal Lobar Degeneration


subject: CHEBI:64312

object_name: GRN-related frontotemporal dementia


subject: CHEBI:8378

object_name: biliary atresia


subject: UMLS:C0700792

subject_name: Ursolvan

object_name: retinal detachment


subject: UMLS:C0700792

object_name: Retinal Detachment, CTCAE 3.0


subject: UMLS:C0700792

object_name: Retinal Detachment, CTCAE 5.0


subject: CHEBI:9907

subject_name: ursodiol


subject: CHEBI:9907


subject: CHEBI:9907


subject: UMLS:C0950934

object_name: endogenous depression


subject: UMLS:C0950934

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:118059983


subject: PUBCHEM.COMPOUND:118059983

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:118059983

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C3852625

object_name: Acute Pain


subject: UNII:1ER2O3UZ4W

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C1144709

subject_name: Natriuretic Peptides

object_name: Headache


subject: UMLS:C1144709

object_name: Headache, CTCAE


subject: UMLS:C1144709

object_name: migraine


subject: UMLS:C1144709

object_name: migraine with or without aura, susceptibility to, 1


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: early T cell progenitor acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: mixed phenotype acute leukemia,T/myeloid


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:7936

subject_name: Paroxetine

object_name: fibromyalgia


subject: UMLS:C5706381

subject_name: Emunkitug

object_name: Stomach cancer


subject: UMLS:C5706381

object_name: gastric cancer


subject: UMLS:C5706381

object_name: cervical cancer


subject: UMLS:C5706381

object_name: cervical carcinoma


subject: UMLS:C5706381

object_name: non-small cell lung carcinoma


subject: UMLS:C5706381

object_name: testicular germ cell tumor 1


subject: UMLS:C5706381

object_name: testicular germ cell tumor


subject: UMLS:C5706381

object_name: childhood testicular germ cell tumor


subject: UMLS:C5706381

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5706381

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5706381

object_name: clear cell renal carcinoma


subject: UMLS:C5706381

object_name: renal cell adenocarcinoma


subject: UMLS:C5706381

object_name: renal cell carcinoma


subject: UMLS:C5706381

object_name: Mesothelioma


subject: UMLS:C5706381

object_name: mesothelial neoplasm


subject: UMLS:C5706381

object_name: malignant mesothelioma


subject: UMLS:C5706381

object_name: melanoma


subject: UMLS:C5706381

object_name: malignant soft tissue neoplasm


subject: UMLS:C5706381

object_name: sarcoma


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UNII:59XC9G796Y

object_name: Parkinson disease


subject: CHEBI:91899

object_name: bronchiolitis obliterans syndrome


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:408174

subject_name: Arformoterol


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Diffuse Astrocytoma, IDH-Wildtype


subject: UMLS:C3827082


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Recurrent Childhood Glioblastoma


subject: UNII:I031V2H011

object_name: Recurrent Glioblastoma


subject: UNII:I031V2H011


subject: CHEBI:80555

subject_name: ENDOXIFEN

object_name: bipolar I disorder


subject: UNII:HB2U71MNOT

subject_name: ENDOXIFEN, (E)-


subject: UNII:H8MTN7XVC2

subject_name: Mitometh

object_name: carcinoma of esophagus


subject: UNII:H8MTN7XVC2

object_name: esophageal cancer


subject: UNII:H8MTN7XVC2

object_name: Childhood Esophageal Carcinoma


subject: UNII:H8MTN7XVC2

object_name: neoplasm of esophagus


subject: PR:000029794

subject_name: mitochondrial import inner membrane translocase subunit Tim8 A


subject: PR:000029794


subject: PR:000029794


subject: PR:000029794


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine

object_name: inherited hemoglobinopathy


subject: PUBCHEM.COMPOUND:4739

object_name: hemoglobinopathy


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: CHEBI:27834


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Carcinoma breast stage IV


subject: CHEBI:229221

object_name: Her2-receptor negative breast cancer


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UNII:43K1W2T1M6

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735


subject: UMLS:C0021735

object_name: mycosis fungoides


subject: UMLS:C5552625

subject_name: Interferon alfa-2b [EPC]


subject: UMLS:C5552625


subject: UMLS:C5552625


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: UMLS:C0722264

subject_name: Ontak

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:2569

subject_name: Alfentanil

object_name: no feeling or sensation of skin


subject: CHEBI:2569

object_name: Sensory Loss


subject: UMLS:C2346741

object_name: plasma cell myeloma


subject: UMLS:C2346741

object_name: Myelodysplasia


subject: UMLS:C2346741

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C2346741

object_name: childhood myelodysplastic syndrome


subject: UMLS:C2346741

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:95044

subject_name: Tosedostat


subject: CHEBI:95044


subject: CHEBI:95044


subject: CHEBI:95044


subject: CHEBI:95044


subject: CHEBI:133021

subject_name: Venetoclax

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: CHEBI:134689

subject_name: Rucaparib

object_name: Metastatic urothelial carcinoma


subject: CHEBI:134689

object_name: ureter carcinoma


subject: CHEBI:134689

object_name: carcinoma of urethra


subject: CHEBI:134689

object_name: renal pelvis carcinoma


subject: CHEBI:134689

object_name: urinary bladder carcinoma


subject: CHEBI:134689

object_name: bladder tumor


subject: CHEBI:134689

object_name: urinary bladder cancer


subject: CHEBI:134689

object_name: childhood bladder carcinoma


subject: CHEBI:61057

object_name: Evans syndrome


subject: CHEBI:61057

object_name: autoimmune hemolytic anemia


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Light - subjective measurement


subject: UMLS:C1527137

object_name: Glucose^1.5H post dose glucagon


subject: UMLS:C1527137

object_name: glucose measurement


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:131166

subject_name: Berzosertib

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:131166

object_name: Unresectable Colorectal Carcinoma


subject: CHEBI:131166

object_name: stage IV pancreatic cancer


subject: CHEBI:131166

object_name: Unresectable Lung Small Cell Carcinoma


subject: CHEBI:131166

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:131166

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:131166

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:131166

object_name: Refractory Pancreatic Carcinoma


subject: CHEBI:131166

object_name: Refractory Lung Small Cell Carcinoma


subject: CHEBI:131166

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEBI:131166

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:131166

object_name: Refractory Colorectal Carcinoma


subject: CHEBI:131166

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: PR:000004692

subject_name: Bcl-2-related protein A1

object_name: rifampicin-resistant tuberculosis


subject: PR:000004692

object_name: multidrug-resistant tuberculosis


subject: PR:000004692


subject: PUBCHEM.COMPOUND:40977


subject: PUBCHEM.COMPOUND:40977


subject: PUBCHEM.COMPOUND:40977


subject: PR:000012880

subject_name: proteolipid protein 2


subject: PR:000012880


subject: PR:000012880


subject: PR:000004168

subject_name: amyloid-beta precursor protein


subject: PR:000004168


subject: PR:000004168


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Chronic ulcer of lower extremity


subject: UMLS:C3827073

object_name: Gene Rearrangement Abnormality


subject: CHEBI:174690

subject_name: Clenbuterol

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:174690

object_name: amyotrophic lateral sclerosis


subject: CHEBI:2677

subject_name: Augmentin

object_name: otitis media


subject: CHEBI:2677

object_name: infectious otitis media


subject: CHEBI:2677

object_name: Otitis Media, CTCAE


subject: CHEBI:2677

object_name: respiratory tract infectious disorder


subject: RXCUI:151392


subject: RXCUI:151392


subject: RXCUI:151392


subject: RXCUI:151392


subject: CHEBI:33393

subject_name: Einsteinium


subject: CHEBI:33393


subject: CHEBI:33393


subject: CHEBI:33393


subject: CHEBI:73509

subject_name: Glu-Ser


subject: CHEBI:73509


subject: CHEBI:73509


subject: CHEBI:73509


subject: CHEBI:134738

subject_name: Laquinimod

object_name: Huntington disease


subject: DRUGBANK:DB14297

subject_name: Arnica montana

object_name: Wound healed (finding)


subject: PUBCHEM.COMPOUND:74981710

subject_name: Bromelain


subject: UMLS:C0006217

subject_name: bromelains


subject: UMLS:C0293742

subject_name: stem bromelain


subject: UMLS:C0350411

subject_name: Oxygen only product in gas for inhalation

object_name: Chronic obstructive pulmonary disease exacerbation


subject: UMLS:C0350411

object_name: COPD exacerbation


subject: CHEBI:31355

subject_name: Carboplatin

object_name: brain cancer


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021

object_name: brain neoplasm


subject: CHEBI:63724


subject: CHEBI:63724


subject: MESH:C541234

subject_name: diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine

object_name: meningococcal infection


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: cardiovascular surgery result: angina


subject: UMLS:C0001645

object_name: Angina pectoris


subject: CHEBI:38215

subject_name: calcium channel blocker


subject: CHEBI:38215


subject: UMLS:C0006684

subject_name: Calcium Channel Blockers


subject: UMLS:C0006684


subject: UMLS:C3536851

subject_name: Calcium Channel Blocker [EPC]


subject: UMLS:C3536851


subject: CHEBI:177298

object_name: Adenocarcinoma of the prostate metastatic


subject: CHEBI:177298

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8426

subject_name: Probenecid

object_name: Medication interaction potentiation


subject: PUBCHEM.COMPOUND:20473337

subject_name: Diethylcarbamazine

object_name: parasitic infectious disease


subject: PUBCHEM.COMPOUND:20473337

object_name: filariasis


subject: PUBCHEM.COMPOUND:20473337

object_name: Infection by Filaroides


subject: PUBCHEM.COMPOUND:20473337

object_name: mansonelliasis


subject: PUBCHEM.COMPOUND:20473337

object_name: helminthiasis


subject: UMLS:C4060043

subject_name: Interleukin-5 Antagonist

object_name: asthma


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Neck Carcinoma